A synthetic 36-amino acid peptide that corresponds to the heptad repeat sequence of HIV-1 gp41. It blocks HIV cell fusion and viral entry and is used with other anti-retrovirals for combination therapy of HIV INFECTIONS and AIDS.
Enfuvirtide has been studied across 11 research domains including 🧠 Focus & Attention, 😴 Sleep, 🫁 Liver & Detox, 🔬 Oncology, ✨ Skin & Hair. The primary research focus is 🧠 Focus & Attention with 4% of studies addressing this area.
This evidence profile for Enfuvirtide is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.